Vectorious Medical Technologies

Vectorious Medical Technologies develops novel treatment for heart failure patients which is based on physician directed, patients self-management paradigm. Leveraging its advanced, first of its kind, implantable V-LAP platform, which harvests valuable information from the hearts left atrium, physicians and patients can monitor and manage disease status, prevent hospitalizations and improve quality of life. The V-LAP system is an investigational device which is currently under evaluation in multiple clinical studies in Europe, Israel and the U.S

Medical devices,wireless communication,miniature implants,heart failure,remote monitoring,and sensors

Vectorious medical technologies operates in the Medical equipment manufacturing industry.

Vectorious medical technologies's revenue is 11m - 100m

Vectorious medical technologies has 51 - 200 employees.